Safety, Tolerability and early signs of efficacy with riociguat for the treatment of adult PHE508DEL homozygous cystic fibrosis patients: safety data from the RIO-CF study
2017
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI